COMMUNIQUÉS West-GlobeNewswire

Sonoma Pharmaceuticals Reports First Quarter FY 2019 Financial Results

08/08/2018 - 22:05

Total Revenue up 20 % over March 2018 Quarter Total Revenue up 14% over June 2017 Quarter Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. ( [...]

OraSure Announces 2018 Second Quarter Financial Results

08/08/2018 - 22:05

BETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results [...]

OrthoPediatrics Corp. Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

Record Revenue of $15.1 Million, Up 27.7% Year-over-Year WARSAW, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics [...]

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018

08/08/2018 - 22:05

Reports Net Revenues of $71.0 Million for the Three Months Ended June 30, 2018 RANCHO CUCAMONGA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) [...]

Assure Holdings Corp. Announces Update

08/08/2018 - 22:05

DENVER, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services announces that it expects to file unaudited [...]

Assembly Biosciences Announces Second Quarter 2018 Financial Results

08/08/2018 - 22:05

- ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Initial Data Continues to be Anticipated in H1 2019 - Strong Balance Sheet Provides Significant Runway SAN FRANCISCO and INDIANAPOLIS, Aug. 08, 2018 ( [...]

Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 22:05

MENLO PARK, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today reported [...]

Novavax Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

Novavax Delivers on Key Milestones Supporting its 2018 Objectives Company to Host Conference Call Today at 4:30 pm ET GAITHERSBURG, Md., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its [...]

TRACON Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 22:05

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

CytomX Therapeutics Announces Second Quarter 2018 Financial Results

08/08/2018 - 22:04

- Presentation of First-in-Human Data Demonstrated Encouraging Safety and Efficacy Profile of CX-072 as Monotherapy and in Combination with ipilimumab (Yervoy®) - - Preliminary Proof-of-Concept for Probody™ Platform and [...]

Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference

08/08/2018 - 22:03

CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

MyoKardia Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:02

Company to Host Conference Call and Webcast Today at 4:30 p.m. ET (1:30 p.m. PT) SOUTH SAN FRANCISCO, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company [...]

Sarepta Therapeutics Announces Second Quarter 2018 Financial Results and Recent Corporate Developments

08/08/2018 - 22:02

Second quarter 2018 EXONDYS 51® (eteplirsen) total net revenues of $73.5 million CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical [...]

Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results

08/08/2018 - 22:01

REDWOOD CITY, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today reviewed corporate highlights and reported financial results for the quarter ended June 30, 2018. Second Quarter [...]

Collegium Reports Second Quarter Financial Results and Provides Corporate Update

08/08/2018 - 22:01

Net revenue $73.1 million for the second quarter of 2018, 1,952% increase vs second quarter 2017, 15% vs first quarter 2018 Xtampza ER prescriptions grew by 23% in the second quarter of 2018 Cash balance at end of 2018 [...]

Celldex Provides Corporate Update and Reports Second Quarter 2018 Results

08/08/2018 - 22:01

HAMPTON, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2018. The Company will host a conference [...]

Chembio Diagnostics Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:01

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic testing, today reported financial results for the second quarter ended June 30, 2018. [...]

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress

08/08/2018 - 22:01

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes [...]

Reata Pharmaceuticals, Inc. Announces Second Quarter 2018 Financial Results and an Update on Development Programs

08/08/2018 - 22:01

IRVING, Texas, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company's product development programs and [...]